The University of Vermont Inc.
Welcome,         Profile    Billing    Logout  
 3 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sullivan, Jillian
AMAY, NCT05509777 / 2022-000811-29: A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

Recruiting
3
90
Europe, Canada, Japan, US, RoW
Mirikizumab, LY3074828
Eli Lilly and Company, Eli Lilly and Company
Crohn's Disease
07/27
10/27
NCT06191640: Sinus Disease in Young Children With Cystic Fibrosis

Recruiting
N/A
80
US
Ivacaftor or elexacaftor/tezacaftor/ivacaftor, Kalydeco or Trikafta; Vertex (VX)-770 or VX-445/VX-661/VX-770
University of California, Los Angeles, University of Kansas Medical Center, Children's Hospital Medical Center, Cincinnati, University of Iowa, University of Virginia, Children's Hospital Colorado, University of Vermont
Cystic Fibrosis in Children, Cystic Fibrosis, Chronic Rhinosinusitis (Diagnosis), Olfactory Disorder, Olfactory Impairment
04/26
04/26
Sweet, Julie
ABATE, NCT04294043: IV Gallium Study for Patients with Cystic Fibrosis Who Have NTM ( Study)

Recruiting
1
40
US
Gallium nitrate, Ga, GaN3O9, IV gallium, ganite
Chris Goss, Cystic Fibrosis Foundation
Nontuberculous Mycobacterium Infection
06/25
06/25
NCT06191640: Sinus Disease in Young Children With Cystic Fibrosis

Recruiting
N/A
80
US
Ivacaftor or elexacaftor/tezacaftor/ivacaftor, Kalydeco or Trikafta; Vertex (VX)-770 or VX-445/VX-661/VX-770
University of California, Los Angeles, University of Kansas Medical Center, Children's Hospital Medical Center, Cincinnati, University of Iowa, University of Virginia, Children's Hospital Colorado, University of Vermont
Cystic Fibrosis in Children, Cystic Fibrosis, Chronic Rhinosinusitis (Diagnosis), Olfactory Disorder, Olfactory Impairment
04/26
04/26
BEGIN, NCT04509050: Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

Recruiting
N/A
210
US
Ivacaftor or elexacaftor/tezacaftor/ivacaftor, Kalydeco or Trikafta, Vertex (VX)-770 or VX-445/VX-661/VX-770
Sonya Heltshe, Cystic Fibrosis Foundation, University of Washington, University of Alabama at Birmingham
Cystic Fibrosis
12/29
12/29

Download Options